Stock Events

Stock Events

Seres Therapeutics (MCRB) Q1 2025 Earnings

13MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-3.93

-2.43

-0.92

0.58

Details

Expected EPS

-3.930115

Actual EPS

-1.8

Surprise EPS

2.13

Surprise Percent

+54.2%

Description

Seres Therapeutics (MCRB) has reported earnings of -1.8 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.